Tayleur D. White, Abdulaziz Almutairi, Ying Gai-Tusing, Daniel J. Stephenson, Benjamin D. Stephenson, Charles E. Chalfant, Xiaoyong Lei, Brian Lu, Bruce D. Hammock, Teresa P. DiLorenzo, Sasanka Ramanadham
{"title":"Differential lipid signaling from CD4+ and CD8+ T cells contributes to type 1 diabetes development","authors":"Tayleur D. White, Abdulaziz Almutairi, Ying Gai-Tusing, Daniel J. Stephenson, Benjamin D. Stephenson, Charles E. Chalfant, Xiaoyong Lei, Brian Lu, Bruce D. Hammock, Teresa P. DiLorenzo, Sasanka Ramanadham","doi":"10.3389/fimmu.2024.1444639","DOIUrl":null,"url":null,"abstract":"IntroductionWe reported that Ca<jats:sup>2+</jats:sup>-independent phospholipase A<jats:sub>2</jats:sub>β (iPLA<jats:sub>2</jats:sub>β)–derived lipids (iDLs) contribute to type 1 diabetes (T1D) onset. As CD4<jats:sup>+</jats:sup> and CD8<jats:sup>+</jats:sup> T cells are critical in promoting β-cell death, we tested the hypothesis that iDL signaling from these cells participates in T1D development.MethodsCD4<jats:sup>+</jats:sup> and CD8<jats:sup>+</jats:sup> T cells from wild-type non-obese diabetic (<jats:italic>NOD</jats:italic>) and <jats:italic>NOD</jats:italic>.<jats:italic>iPLA<jats:sub>2</jats:sub>β<jats:sup>+/-</jats:sup></jats:italic> (NOD<jats:italic>.HET</jats:italic>) mice were administered in different combinations to immunodeficient NOD.<jats:italic>scid</jats:italic>.ResultsIn mice receiving only <jats:italic>NOD</jats:italic> T cells, T1D onset was rapid (5 weeks), incidence 100% by 20 weeks, and islets absent. In contrast, onset was delayed 1 week and incidence reduced 40%–50% in mice receiving combinations that included NOD<jats:italic>.HET</jats:italic> T cells. Consistently, islets from these non-diabetic mice were devoid of infiltrate and contained insulin-positive β-cells. Reduced iPLA<jats:sub>2</jats:sub>β led to decreased production of proinflammatory lipids from CD4<jats:sup>+</jats:sup> T cells including prostaglandins and dihydroxyeicosatrienoic acids (DHETs), products of soluble epoxide hydrolase (sEH), and inhibition of their signaling decreased (by 82%) IFNγ<jats:sup>+</jats:sup>CD4<jats:sup>+</jats:sup> cells abundance. However, only DHETs production was reduced from CD8<jats:sup>+</jats:sup> T cells and was accompanied by decreases in <jats:italic>sEH</jats:italic> and <jats:italic>granzyme B</jats:italic>.DiscussionThese findings suggest that differential select iDL signaling in CD4<jats:sup>+</jats:sup> and CD8<jats:sup>+</jats:sup> T cells contributes to T1D development, and that therapeutics targeting such signaling might be considered to counter T1D.","PeriodicalId":12622,"journal":{"name":"Frontiers in Immunology","volume":null,"pages":null},"PeriodicalIF":5.7000,"publicationDate":"2024-09-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Frontiers in Immunology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3389/fimmu.2024.1444639","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"IMMUNOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
IntroductionWe reported that Ca2+-independent phospholipase A2β (iPLA2β)–derived lipids (iDLs) contribute to type 1 diabetes (T1D) onset. As CD4+ and CD8+ T cells are critical in promoting β-cell death, we tested the hypothesis that iDL signaling from these cells participates in T1D development.MethodsCD4+ and CD8+ T cells from wild-type non-obese diabetic (NOD) and NOD.iPLA2β+/- (NOD.HET) mice were administered in different combinations to immunodeficient NOD.scid.ResultsIn mice receiving only NOD T cells, T1D onset was rapid (5 weeks), incidence 100% by 20 weeks, and islets absent. In contrast, onset was delayed 1 week and incidence reduced 40%–50% in mice receiving combinations that included NOD.HET T cells. Consistently, islets from these non-diabetic mice were devoid of infiltrate and contained insulin-positive β-cells. Reduced iPLA2β led to decreased production of proinflammatory lipids from CD4+ T cells including prostaglandins and dihydroxyeicosatrienoic acids (DHETs), products of soluble epoxide hydrolase (sEH), and inhibition of their signaling decreased (by 82%) IFNγ+CD4+ cells abundance. However, only DHETs production was reduced from CD8+ T cells and was accompanied by decreases in sEH and granzyme B.DiscussionThese findings suggest that differential select iDL signaling in CD4+ and CD8+ T cells contributes to T1D development, and that therapeutics targeting such signaling might be considered to counter T1D.
期刊介绍:
Frontiers in Immunology is a leading journal in its field, publishing rigorously peer-reviewed research across basic, translational and clinical immunology. This multidisciplinary open-access journal is at the forefront of disseminating and communicating scientific knowledge and impactful discoveries to researchers, academics, clinicians and the public worldwide.
Frontiers in Immunology is the official Journal of the International Union of Immunological Societies (IUIS). Encompassing the entire field of Immunology, this journal welcomes papers that investigate basic mechanisms of immune system development and function, with a particular emphasis given to the description of the clinical and immunological phenotype of human immune disorders, and on the definition of their molecular basis.